Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4263712 | 3867483 | F | 1 | 4263712-9 | 20020916 | 20031217 | 20040102 | EXP | 166743 | BIOGEN, IDEC | 35 | YR | F | N | 20031231 | MD |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4263712 | 1004492615 | PS | AVONEX | 1 | INTRAMUSCULAR | 30 MCG QW IM | Y | N | |||
| 4263712 | 1004518807 | SS | AVONEX | 1 | INTRAMUSCULAR | 30 MCG QW IM | Y | N | |||
| 4263712 | 1004518808 | C | DOLIPRANE | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4263712 | 1004492615 | MULTIPLE SCLEROSIS |
| 4263712 | 1004518807 | MULTIPLE SCLEROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4263712 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4263712 | ALANINE AMINOTRANSFERASE INCREASED |
| 4263712 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 4263712 | GAMMA-GLUTAMYLTRANSFERASE INCREASED |
| 4263712 | HEPATIC ENZYME INCREASED |
| 4263712 | INFLUENZA LIKE ILLNESS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4263712 | FGN |
| 4263712 | HP |
| 4263712 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4263712 | 1004492615 | 19990701 | 20021001 | ||
| 4263712 | 1004518807 | 20030101 |